Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Business

Cambridge warns UK must scale up investment to turn spin-outs into global success stories

by May 27, 2025
May 27, 2025
Cambridge warns UK must scale up investment to turn spin-outs into global success stories

University of Cambridge leaders have issued a stark warning that the UK risks falling behind in the race to commercialise world-class research unless it does more to support academic spin-out companies struggling to scale.

Speaking at a London showcase of Cambridge’s most promising spin-outs, university figures and venture capitalists said that while Britain remains a hub of scientific excellence, it lacks the investment firepower and infrastructure needed to turn breakthrough research into category-defining global businesses.

“The world isn’t waiting for UK and European science to commercialise,” said Gerard Grech (pictured), managing director of Founders, a Cambridge initiative to boost entrepreneurial growth. “Founders in Silicon Valley, Shenzhen and Bangalore are already building, and very, very quickly. The question is: can European universities match that pace without losing the depth that makes our research world-class?”

Grech said that many of the best commercial opportunities emerge when university science interacts with bold capital, adding: “This is where real innovation happens.”

Cambridge’s vice-chancellor, Deborah Prentice, highlighted the university’s strong track record in spin-out formation. Last year, Cambridge spin-outs raised more than $2 billion, and the institution now produces more spin-outs per capita than any other UK university.

“Cambridge is by many measures the highest-performing innovation ecosystem in Europe,” she said. “International investors, large companies and world-class scientists are recognising that we’re punching above our weight — but we need to go further.”

However, the ability to grow these ventures into globally competitive firms remains a major hurdle. Data from Dealroom cited during the event showed that while Cambridge has a healthy pipeline of start-ups with up to $10 million in venture capital, the number of firms that go on to raise $100 million or more remains significantly lower than in Silicon Valley.

“That is the problem. It is as simple as that,” said Suranga Chandratillake, general partner at Balderton Capital. “You can build so much of a business with $10 million, $20 million, or $30 million. But you need hundreds of millions to build truly global, category-defining companies. And we just don’t have enough companies raising that kind of money.”

The showcase featured pitches from several early-stage, high-impact ventures looking to address complex medical problems. Prodromic, for example, is developing predictive diagnostics that could detect the early onset of brain diseases like dementia. Gastrobody Therapeutics is working on ingestible, stable antibodies for treating gastrointestinal diseases such as Crohn’s, potentially eliminating the need for injections.

Such innovations demonstrate the commercial potential sitting within UK universities, but investors and academics alike warned that unless Britain finds a way to provide follow-on capital at scale, these businesses may never realise their full potential — or may end up relocating abroad.

The message from Cambridge was clear: if the UK wants to turn scientific leadership into economic leadership, it must urgently improve its ability to fund, grow and retain its most promising ventures.

With international capital accelerating elsewhere, and breakthrough research already happening on British soil, the missing piece is not invention — it’s investment at scale.

Read more:
Cambridge warns UK must scale up investment to turn spin-outs into global success stories

0
FacebookTwitterGoogle +Pinterest
previous post
BGF pledges £3 billion to support UK growth businesses, with £300 million aimed at female-led firms
next post
Oxford Brain Diagnostics to roll out revolutionary dementia technology following UK and US regulatory approvals

You may also like

New research reveals that unfilled tech vacancies are...

April 3, 2023

New Brexit trading rules could take more than...

March 7, 2023

6 Workplace Safety Tips For Every Employee

March 13, 2023

Government help for mortgage holders is being help...

June 19, 2023

Presenter Kaye Adams wins IR35 case against HMRC...

November 29, 2023

Company insolvencies jump 27% as high interest rates...

July 18, 2023

Mattel Introduces New Cooperative Scrabble Mode to Foster...

April 9, 2024

Isle of Man to freeze electricity prices until...

August 26, 2022

Dental Implants Middlesbrough: A Complete Overview

September 12, 2024

AimHi Earth secures £1 million to transform businesses...

May 12, 2024

New research reveals that unfilled tech vacancies are...

April 3, 2023

New Brexit trading rules could take more than...

March 7, 2023

6 Workplace Safety Tips For Every Employee

March 13, 2023

Government help for mortgage holders is being help...

June 19, 2023

Presenter Kaye Adams wins IR35 case against HMRC...

November 29, 2023

Company insolvencies jump 27% as high interest rates...

July 18, 2023

Mattel Introduces New Cooperative Scrabble Mode to Foster...

April 9, 2024

Isle of Man to freeze electricity prices until...

August 26, 2022

Dental Implants Middlesbrough: A Complete Overview

September 12, 2024

AimHi Earth secures £1 million to transform businesses...

May 12, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Meet ‘China’s man in Lima’ who jetted over to US to collect trains donated by Biden admin

      July 12, 2025
    • Inside Dan Bongino’s tense meeting with White House officials over Jeffrey Epstein fallout

      July 12, 2025
    • Could Butler happen again? Former Secret Service agents weigh in on political violence in 2025

      July 12, 2025
    • DAVID MARCUS: Trump is flunking his MAGA base’s Jeffrey Epstein test

      July 12, 2025
    • A Deep Dive into Duron Ontario Ltd.’s Construction Career

      July 12, 2025
    • One in six UK workers struggling to pay bills as second jobs hit record high

      July 12, 2025

    Categories

    • Business (8,456)
    • Investing (2,118)
    • Politics (16,015)
    • Stocks (3,205)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved